Biogen Inc

NASDAQ:BIIB   3:59:59 PM EDT
388.44
+4.92 (+1.28%)
Products, Strategic Combinations

Biogen And Ginkgo Bioworks Announce Collaboration And License Agreement To Develop Novel Gene Therapy Manufacturing Platform

Published: 05/21/2021 11:39 GMT
Biogen Inc (BIIB) - Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform.
Biogen Inc - Ginkgo to Receive $5 Million Upfront Payment and is Eligible for Up to $115 Million in Potential Research, Development, and Commercial Milestones.
Biogen Inc - Biogen Will Receive Access to Ginkgo's Proprietary Cell Programming Platform and Capabilities.